ArticleClinical ophthalmology (Auckland, N.Z.)2022

Early Canadian Real-World Experience with Brolucizumab in Anti-Vascular Endothelial Growth Factor-Experienced Patients with Neovascular Age-Related Macular Degeneration: A Retrospective Chart Review.

Michel Giunta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.